ATE277940T1 - Aryl-phosphate derivative von d4t mit anti-hiv wirkung - Google Patents

Aryl-phosphate derivative von d4t mit anti-hiv wirkung

Info

Publication number
ATE277940T1
ATE277940T1 AT99932080T AT99932080T ATE277940T1 AT E277940 T1 ATE277940 T1 AT E277940T1 AT 99932080 T AT99932080 T AT 99932080T AT 99932080 T AT99932080 T AT 99932080T AT E277940 T1 ATE277940 T1 AT E277940T1
Authority
AT
Austria
Prior art keywords
aryl
derivatives
phosphate derivatives
group
hiv
Prior art date
Application number
AT99932080T
Other languages
English (en)
Inventor
Fatih M Uckun
Rakesh Vig
Original Assignee
Parker Hughes Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parker Hughes Inst filed Critical Parker Hughes Inst
Application granted granted Critical
Publication of ATE277940T1 publication Critical patent/ATE277940T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT99932080T 1998-06-29 1999-06-29 Aryl-phosphate derivative von d4t mit anti-hiv wirkung ATE277940T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/107,716 US6030957A (en) 1998-06-29 1998-06-29 Aryl phosphate derivatives of d4T having anti-HIV activity
PCT/US1999/014774 WO2000000501A1 (en) 1998-06-29 1999-06-29 ARYL PHOSPHATE DERIVATIVES OF d4T HAVING ANTI-HIV ACTIVITY

Publications (1)

Publication Number Publication Date
ATE277940T1 true ATE277940T1 (de) 2004-10-15

Family

ID=22318071

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99932080T ATE277940T1 (de) 1998-06-29 1999-06-29 Aryl-phosphate derivative von d4t mit anti-hiv wirkung

Country Status (14)

Country Link
US (7) US6030957A (de)
EP (1) EP1090018B1 (de)
JP (1) JP2002519355A (de)
KR (1) KR20010071673A (de)
CN (1) CN1314909A (de)
AT (1) ATE277940T1 (de)
AU (1) AU4846999A (de)
BR (1) BR9911685A (de)
CA (1) CA2336285A1 (de)
DE (1) DE69920696T2 (de)
HU (1) HUP0102527A3 (de)
IL (1) IL140388A0 (de)
NO (1) NO20006685L (de)
WO (1) WO2000000501A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070015733A1 (en) * 1998-06-29 2007-01-18 Parker Hughes Institute Aryl Phosphate Derivatives of d4T having Activity Against Resistant HIV Strains
US7144874B2 (en) * 2002-10-25 2006-12-05 Parker Hughes Institute Aryl phosphate derivatives of d4T having activity against resistant HIV strains
US6030957A (en) * 1998-06-29 2000-02-29 Wayne Hughes Institute Aryl phosphate derivatives of d4T having anti-HIV activity
WO2000056750A1 (en) * 1999-03-19 2000-09-28 Parker Hughes Institute One pot synthesis of 5'-hydroxy phosphorylated nucleoside derivatives, and compounds formed thereby
US6825177B2 (en) * 2000-10-30 2004-11-30 Parker Hughes Institute Aryl phosphate derivatives of d4T with potent anti-viral activity
ES2240234T3 (es) * 2000-11-13 2005-10-16 Parker Hughes Institute Derivados de fosfato de arilo de d4t.
US7405202B2 (en) * 2002-05-28 2008-07-29 Regents Of The University Of Minnesota CRISP polypeptides as contraceptives and inhibitors of sperm capacitation
US20030236218A1 (en) * 2002-06-12 2003-12-25 Uckun Fatih M. Aryl phosphate derivatives of d4T with selective activity against adenovirus and HIV
US20040076931A1 (en) * 2002-10-18 2004-04-22 Cashflow Technologies, Inc. Educational interactive games
US20040077607A1 (en) * 2002-10-21 2004-04-22 Uckun Fatih M. Aryl phosphate derivatives of d4T with potent anti-viral activity against hemorrhagic fever viruses
GB0401088D0 (en) 2004-01-19 2004-02-18 Univ Cardiff Phosphoramidate derivatives
EP1773355B1 (de) * 2004-06-24 2014-06-25 Merck Sharp & Dohme Corp. Nukleosid-aryl-phosporamidate zur behandlung von rna-abhängiger rna-viralinfektion
WO2006026656A1 (en) * 2004-08-31 2006-03-09 Parker Hughes Institute Cytotoxic nucleoside analog compound 003 for treating cancer
EP1827460A4 (de) 2004-12-09 2012-03-14 Univ Minnesota Nucleoside mit antiviraler und anti-krebs-wirkung
KR20080003789A (ko) * 2005-03-09 2008-01-08 더 리전츠 오브 더 유니버시티 오브 캘리포니아 나노복합체막 및 이의 제조 및 사용 방법
US7892618B2 (en) 2005-03-21 2011-02-22 Sony Corporation Deterring theft of optical media
GB0623493D0 (en) * 2006-11-24 2007-01-03 Univ Cardiff Chemical compounds
EP2408306A4 (de) * 2009-03-20 2012-11-07 Alios Biopharma Inc Substituierte nukleosid- und nukleotid-analoga
SG188497A1 (en) 2010-09-22 2013-05-31 Alios Biopharma Inc Substituted nucleotide analogs
CN103403014B (zh) * 2011-01-03 2016-07-06 河南美泰宝生物制药有限公司 O-(经取代的苯甲基)氨基磷酸酯化合物及其治疗用途
CA2860234A1 (en) 2011-12-22 2013-06-27 Alios Biopharma, Inc. Substituted phosphorothioate nucleotide analogs
US8916538B2 (en) 2012-03-21 2014-12-23 Vertex Pharmaceuticals Incorporated Solid forms of a thiophosphoramidate nucleotide prodrug
WO2013142157A1 (en) 2012-03-22 2013-09-26 Alios Biopharma, Inc. Pharmaceutical combinations comprising a thionucleotide analog
CA2909270A1 (en) 2013-04-12 2014-10-16 Achillion Pharmaceuticals, Inc. Highly active nucleoside derivative for the treatment of hcv

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4707362A (en) 1985-02-15 1987-11-17 Biotek, Inc. Sustained release composition
US4841039A (en) 1986-05-01 1989-06-20 Emory University 2',3'-dideoxy-5-substituted uridines and related compounds as antiviral agents
US4983393A (en) 1987-07-21 1991-01-08 Maximed Corporation Intra-vaginal device and method for sustained drug release
JPH06189998A (ja) 1992-11-06 1994-07-12 C & Co:Yugen コンド―ム
EP0626970A1 (de) 1992-12-18 1994-12-07 The University Of Alberta Dihydropyrimidin nucleoside mit antivirale aktivität
ZA947572B (en) 1993-09-29 1995-09-28 Hampton Roads Medical College Contraceptive compositions
US5672698A (en) * 1993-11-15 1997-09-30 Bristol-Myers Squibb Co. Preparation of 2',3'-didehydro-3'-deoxythymidine from 5-methyluridine
US5659023A (en) * 1995-02-01 1997-08-19 Gilead Sciences, Inc. Nucleotide analogues
GB9505025D0 (en) * 1995-03-13 1995-05-03 Medical Res Council Chemical compounds
CN1177594C (zh) 1996-05-09 2004-12-01 传染病研究股份有限公司 预防治疗粘膜皮肤各种感染 (特别是包括人类免疫缺陷病毒的性传播性疾病 )、炎症、赘生物或其他类型疾病的方法和制剂
US6030957A (en) * 1998-06-29 2000-02-29 Wayne Hughes Institute Aryl phosphate derivatives of d4T having anti-HIV activity

Also Published As

Publication number Publication date
DE69920696T2 (de) 2006-03-02
US6670336B1 (en) 2003-12-30
AU4846999A (en) 2000-01-17
IL140388A0 (en) 2002-02-10
US6537975B1 (en) 2003-03-25
US6030957A (en) 2000-02-29
HUP0102527A2 (hu) 2001-12-28
JP2002519355A (ja) 2002-07-02
BR9911685A (pt) 2001-12-18
EP1090018B1 (de) 2004-09-29
HUP0102527A3 (en) 2002-04-29
DE69920696D1 (de) 2004-11-04
CA2336285A1 (en) 2000-01-06
WO2000000501A1 (en) 2000-01-06
US6350736B1 (en) 2002-02-26
NO20006685L (no) 2001-02-28
US6503890B1 (en) 2003-01-07
US6528495B1 (en) 2003-03-04
KR20010071673A (ko) 2001-07-31
NO20006685D0 (no) 2000-12-28
EP1090018A1 (de) 2001-04-11
CN1314909A (zh) 2001-09-26
US20040171577A1 (en) 2004-09-02
US7071176B2 (en) 2006-07-04

Similar Documents

Publication Publication Date Title
ATE277940T1 (de) Aryl-phosphate derivative von d4t mit anti-hiv wirkung
ES2149267T3 (es) Carbonilos ciclicos substituidos y derivados de los mismos utiles como inhibidores de la proteasa retroviral.
PT942904E (pt) Derivados de 3-tiocarbamoilpirazol como pesticidas
ES2059296T1 (es) Inhibidores de proteasa retroviral.
ES2123065T3 (es) Hidroxietilamino-sulfonamidas utiles como inhibidores de proteasas retroviricas.
ES2059293T3 (es) Inhibidores de proteasas retrovirales.
ES2178037T3 (es) Derivados de ciclosporina, su preparacion y las composiciones farmaceuticas que los contienen.
DE69610627T2 (de) Neuartige peptidderivate
TR199903148T2 (xx) Antimetastatik ve antit�m�r etkinli�i olan barbit�rik asit t�revleri.
DE69126987D1 (de) Retrovirale protease-inhibitoren
PT1023267E (pt) Compostos de piridilo e composicoes farmaceuticas que os contem
EA200000826A1 (ru) Галоидированные производные амидиноаминокислот, применимые в качестве ингибиторов no-синтазы
NO911600D0 (no) Fremgangsmaate for fremstilling av n-(3-fluor-2-fosfonyl-metoksypropyl)-derivater av heterocykliske purin- og pyrimidinbaser.
ATE130315T1 (de) Hirudin-derivate mit verzögerter wirkung.
GR1001597B (el) Νέα βιολογικώς δραστικά παράγωγα εμπουρναμενίνης, φαρμακευτικές συν?έσεις οι οποίες περιέχουν αυτά και μέ?οδος δια την παρασκευή αυτών.
DE60020891D1 (de) Arylphosphatderivate von d4t
ES2097023T3 (es) Derivados del acido succinoilamino-hidroxietilamino-sulfamico utiles como inhibidores de proteasas retrovirales.
ATE113843T1 (de) Verwendung eines prolylendopeptidase-inhibitors zur behandlung von aids.
ITMI911016A1 (it) Aminoacil derivati di acidi gem-difosfonici, un processo per la loro preparazione e composizioni farmaceutiche che li contengono
ES2104416T3 (es) Glicosilamidas de 2-aminoacilamino-2-desoxi-azucares.
HUP9601525A2 (hu) Trombin- és Xa-faktor-gátló hatású peptidil-arginin-aldehid-származékok és a vegyületeket tartalmazó gyógyszerkészítmények
ECSP972237A (es) Derivados de 6,5 heterobiciclicos sustituidos

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties